We are delighted to have the support of our lead media partners, The Cell & Gene Curator and The Medicine Maker.
We will be working with them to ensure the launch edition of Advanced Therapies Integrates becomes the leading event that facilitates the translation of cutting-edge research and disruptive innovation into the wide-spread adoption of Advanced Therapies, delivering improved patient outcomes and a revolution in healthcare economics.
We also have support from a number of other media and PR organisations. You can find out more below.
If you are a member of the press and would like to attend this event, please request a press pass by clicking on the image on the right of the page.
We welcome enquiries from other media partners who would like to work with us. If this is of interest please contact Jo Stickings.
22 June 2021
LIVE ONLINE
7 October 2021
Over 300 attendees live on the day
The online digital event with real-time, face to face networking
1
day
70+
speakers
300+
senior industry executives
Our lead media partners are:
The Medicine Maker is a global publication that showcases the pharma industry’s success stories and examines its biggest points of contention. Engaging content covers the entire spectrum of drug development, keeping all medicine makers up to date with the most pressing topics, trends and technologies driving the drug development and manufacturing industry forward.
The Cell + Gene Curator is a short, weekly newsletter connecting you to discoveries, process innovation, and business updates from the cell and gene therapy community. We trawl the news, speak with the right people, and dig for research gold to bring you the latest insight, analysis, and words of wisdom from the advanced therapies field.
Do you want to share your news with our community? Our Social Media reach includes 6,700 followers on Twitter and 9,000 connections on LinkedIn. Send your news to info@lsi-uk.com to be included in our communications plan.
Enterprise virtual reality (VR) software provider Immerse has today announced its new partnership with DTG, a digital transformation company that delivers technology and solutions that enable clients to embrace the operational, cultural and financial benefits of digitalisation.
The award win recognizes Nanoform as a listed company that places innovation at the center of its strategy for business development and introduces an innovative technology to the market.
While batch process chemistry remains the standard in the pharmaceutical industry, a clear increase in continuous flow processes has emerged over the past decade thanks to the commercialization of preparative flow reactor units. I
Our lead media partners are:
